These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4228969)

  • 61. [EXPERIMENTAL RESEARCH ON THE PROCESS OF ISOIMMUNIZATION IN GUINEA PIGS. I. IMMUNO-SEROLOGICAL INVESTIGATIONS].
    ILIESCO M; RADU I; BERCEANU S
    Arch Roum Pathol Exp Microbiol; 1963 Mar; 22():57-68. PubMed ID: 14075073
    [No Abstract]   [Full Text] [Related]  

  • 62. SUBSTITUTES FOR THE MYCOBACTERIA IN FREUND'S ADJUVANTS IN THE PRODUCTION OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN THE GUINEA PIG.
    SHAW CM; ALVORD EC; FAHLBERG WJ; KIES MW
    J Immunol; 1964 Jan; 92():28-40. PubMed ID: 14139543
    [No Abstract]   [Full Text] [Related]  

  • 63. Relationships between antibodies and experimental allergic encephalomyelitis. IV. Cytophilic antibodies.
    Gibbs N; Hruby S; Alvord EC; Shaw CM
    Int Arch Allergy Appl Immunol; 1970; 38(4):394-402. PubMed ID: 5415645
    [No Abstract]   [Full Text] [Related]  

  • 64. COMPLEMENT LEVELS IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS.
    TARRANT CJ; FIFE EH; MUSCHEL LH
    Nature; 1964 May; 202():819. PubMed ID: 14187643
    [No Abstract]   [Full Text] [Related]  

  • 65. The effect of Freund's adjuvants on blood-cerebrospinal fluid barrier permeability.
    Reiber H; Suckling AJ; Rumsby MG
    J Neurol Sci; 1984 Jan; 63(1):55-61. PubMed ID: 6699654
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Dyamics of the clinico-immunologic and histopathologic changes in the development of experimental allergic encephalomyelitis].
    Savenko SN; Tauber IN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(2):171-5. PubMed ID: 4173467
    [No Abstract]   [Full Text] [Related]  

  • 67. EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PROTECTION EXPERIMENTS WITH ENCEPHALITOGENIC FACTOR AND TUBERCLE FRACTIONS.
    CUNNINGHAM VR; FIELD EJ
    Ann N Y Acad Sci; 1965 Mar; 122():346-55. PubMed ID: 14313494
    [No Abstract]   [Full Text] [Related]  

  • 68. Protection against experimental allergic encephalomyelitis.
    Teitelbaum D; Webb C; Meshorer A; Arnon R; Sela M
    Nature; 1972 Dec; 240(5383):564-6. PubMed ID: 4119624
    [No Abstract]   [Full Text] [Related]  

  • 69. CHRONIC DISSEMINATED ALLERGIC ENCEPHALOMYELITIS IN GUINEA PIGS.
    STONE SH; LERNER EM
    Ann N Y Acad Sci; 1965 Mar; 122():227-41. PubMed ID: 14313480
    [No Abstract]   [Full Text] [Related]  

  • 70. An immunoelectron microscopical study of the expression of class II MHC and a T lymphocyte surface marker during chronic relapsing experimental allergic encephalomyelitis.
    Butter C; Healey DG; Agha N; Turk JL
    J Neuroimmunol; 1988 Nov; 20(1):45-51. PubMed ID: 3053782
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Experimental studies on drug sensitization. II. Production of antiacetylsalicylyl antibodies and their detection by passive hemagglutination.
    Cîrstea M; Suhaciu G
    Physiologie; 1976; 13(2):135-40. PubMed ID: 59932
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Induction and prevention of allergic experimental encephalomyelitis in guinea pigs. Relationship with in vitro induced injuries and with class and specificity of the autoantibodies produced].
    Lebar R; Boutry JM; Robineaux R; Voisin GA
    C R Acad Hebd Seances Acad Sci D; 1973 Mar; 276(10):1635-8. PubMed ID: 4198380
    [No Abstract]   [Full Text] [Related]  

  • 73. [Immunological studies on experimental allergic encephalomyelitis (EAE). Protection against EAE (author's transl)].
    Nagasawa K
    Fukuoka Igaku Zasshi; 1976 Jun; 67(6):220-33. PubMed ID: 986997
    [No Abstract]   [Full Text] [Related]  

  • 74. Enzymatic changes in various organs of guinea pigs caused by the administration of Freund's complete adjuvant.
    Aoyagi T; Wada T; Nishikiori T; Kojima F; Nagai M; Osanai T; Nagai Y; Umezawa H
    J Pharmacobiodyn; 1983 Dec; 6(12):974-82. PubMed ID: 6201605
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Studies on lymphocyte transformation in experimental allergic encephalomyelitis.
    Warnatz H; Scheiffarth F; Kuntz H
    J Neuropathol Exp Neurol; 1970 Oct; 29(4):575-82. PubMed ID: 5471922
    [No Abstract]   [Full Text] [Related]  

  • 76. The response of the reticuloendothelial system of inbred resistant and susceptible mice in the pathogenesis of allergic encephalomyelitis.
    Böhme D; Lee JM SCHNEIDER HA
    J Neuropathol Exp Neurol; 1966 Apr; 25(2):311-27. PubMed ID: 5936314
    [No Abstract]   [Full Text] [Related]  

  • 77. [Study of the action of adjuvant substances on Staphylococcus albus cultures introduced intraperitonally in guinea pigs].
    Riga S; Riga D; Ciobanu E
    Rev Med Chir Soc Med Nat Iasi; 1970; 74(2):391-6. PubMed ID: 5447567
    [No Abstract]   [Full Text] [Related]  

  • 78. [The activities of some hydrolases after administration of encephalitogenic protein (author's transl)].
    Halcák L; Pechán I
    Cas Lek Cesk; 1974 Nov; 113(47):1452-6. PubMed ID: 4141642
    [No Abstract]   [Full Text] [Related]  

  • 79. [Immunologic characteristics of soluble Rickettsia burneti antigen].
    Kudelina RI
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Jan; 47(1):84-9. PubMed ID: 5448003
    [No Abstract]   [Full Text] [Related]  

  • 80. Protective action of the encephalitogen and other basic proteins in experimental allergic encephalomyelitis.
    Rauch HC; Einstein ER; Csejtey J; Davis WJ
    Immunochemistry; 1968 Nov; 5(6):567-75. PubMed ID: 5702351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.